Access to and Utilization of Endocrine Therapy Among Breast Cancer Survivors in Botswana
BC survivors in Botswana face multilevel barriers to accessing and adhering to ET. Provider and health system improvements are needed to effectively communicate ET importance and increase access to consistently available and affordable medication.
Authors
- Bosa Motladiile
- Tara M. Friebel (ORCID: https://orcid.org/0000-0002-3726-9527)
- Nkhabe Chinyepi (ORCID: https://orcid.org/0000-0002-4866-4418)
- Shahin Lockman (ORCID: https://orcid.org/0000-0002-5384-9716)
- Peter Vuylsteke (ORCID: https://orcid.org/0000-0001-6401-3722)
- Racquel E. Kohler (ORCID: https://orcid.org/0000-0002-1017-3832)
- Scott Dryden‐Peterson (ORCID: https://orcid.org/0000-0002-8487-9731)
- R. Wagner (ORCID: https://orcid.org/0000-0002-8019-5041)
- James R. Wester (ORCID: https://orcid.org/0000-0002-9607-8982)
- Moeketsi J. Makhema
- Isaac Nkele
Institutions
- Rutgers, The State University of New Jersey (US)
- Brigham and Women's Hospital (US)
- Harvard University (US)
- University of Botswana (BW)
- Hospital of the University of Pennsylvania (US)
- Botswana Harvard AIDS Institute Partnership (BW)
- Rutgers Cancer Institute (US)
Publication Details
- Journal
- JCO Global Oncology
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1200/go.24.00180
- Citations
- 3
- Primary Topic
- Economic and Financial Impacts of Cancer
- Type
- article
- Field-Weighted Citation Impact
- 3.39